MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Articles by: HOTSTOCKROCKETS

EPIC
views

A share which could double from its current price because there is blood on the streets…

Trump and tariffs are blamed for the recent market sell off. Or perhaps US equities were grossly overvalued and this kicking, which has infected the rest of the world, was long overdue? Whatever the reason, there is ‘blood on the streets’. We think that US equities remain expensive and so do some UK stocks. But there are also good stocks that have been whacked very unfairly and so now, with blood on the streets, you can make a great return by being brave and buying. Here’s one such idea.
  • By HotStockRockets
  • 2025-04-08 15:30:37
EPIC AMRQ
views

Amaroq Minerals – 2024 results and mineral resource estimate suggest still a winning share tip Buy

Amaroq Minerals (AMRQ) has announced its results for 2024 and an update on planned exploration activities for 2025 as well as a “Significant Increase in Nalunaq Mineral Resource Estimate”. That sounds like further good news from a 90p share price It is, but as explained here, the Icelandic market has puked since Friday and so Amaroq shares are easier thanks to selling, partly to cover margin calls. That should be seen as an opportunity as Iceland will calm down and Amaroq’s fundamentals are better than ever.

  • By HotStockRockets
  • 2025-04-01 11:00:00
  • 1
EPIC WYN
views

Wynnstay Group – AGM trading update, a trading recovery Buy

Agricultural supplies and services group Wynnstay (WYN) has issued an “AGM Update” on trading including that its “trading over the first four months of the financial year… is slightly ahead of the same period last year… in line with the board's expectations” and that “farmgate prices are trending more favourably across most categories, which has helped farmer sentiment”. That all looks to suggest very strong value here from a current 310p to buy the shares.
  • By HotStockRockets
  • 2025-03-28 16:30:00
EPIC SBTX
views

SkinBioTherapeutics – interims, CEO Stuart Ashman contradicts himself again but there’s still a key near-term catalyst

Life science company focused on skin health SkinBioTherapeutics (SBTX) has announced its results for its half-year ended 31st December 2024 with CEO Stuart Ashman arguing the year “represented a drive for growth through the original corporate platform plus the acquisition of value-added businesses (the M&A strategy) to bring scale and synergies”. Has it really worked though?
  • By HotStockRockets
  • 2025-03-27 14:00:39
  • 19
EPIC KEFI
views

Kefi Gold & Copper – exploration licence tender win further enhances potential value from Saudi Arabia

Steve Moore writes: Kefi Gold & Copper (KEFI) has announced that its, currently 15%-owned, joint venture in Saudi Arabia is a 50:50 part of the winning tender for the 910km2 Al Hajar North Exploration Licence after being “selected from 18 multi-billion-dollar groups that participated in the tenders for five mineralised belts”. This should bode further well for the end-result of Kefi “currently engaging with a number of parties with a view… to potentially replace Kefi’s position” in the company’s overall Saudi Arabia joint venture.

  • By HotStockRockets
  • 2025-03-22 08:00:59
EPIC ZTF
views

Zotefoams – 2024 results, growth and value Buy

Materials technology company Zotefoams (ZTF) has announced its results for the 2024 calendar year headlined “Record revenue and profitability form a firm foundation for our next growth phase”. How well does that compare to the valuation from a 298p share price?
  • By HotStockRockets
  • 2025-03-22 08:00:32
Page 1 of 158 (1579 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

Time left: 01:08:23